Overview
Khanh Vu is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Vu is rated as an Experienced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Pulmonary Embolism, Spasticity, Fibrosarcoma, and Mesenchymoma.
Her clinical research consists of co-authoring 41 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Center For Cell And Gene Therapy
Dr. Kamble is Professor of Medicine in Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine and Methodist Hospital, Houston, TX. He graduated from Ravi Shankar University, India in 1986 with a gold medal. He obtained postgraduate residency training from prestigious Postgraduate Institute of Medical Science and Research (PGIMER) Chandigarh, India and his fellowship training in Hematology-Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi. He was junior faculty in the AIIMS before joining MAMC, New Delhi University as Assistant Professor of Medicine. Between 1997 and 2001, he completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from University of Tennessee and University of Arkansas for Medical Sciences respectively. He has served as Assistant Professor of Medicine and Associate director of Hematology-Oncology fellowship program at Oklahoma University Health Sciences Center (OUHSC). Dr. Kamble is primarily interested in hematologic malignancies including multiple myeloma and hematopoietic stem cell transplantation. He was conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in Internal Medicine and Medical Oncology. He has published extensively in prestigious journals including, Blood, Biology of Bone marrow transplantation and Journal of Clinical Oncology and regularly reviews manuscripts for Blood, Biology of bone marrow transplantation and Bone marrow transplant. Dr. Kamble's clinical interests are in innovative reduced conditioning protocols, in vivo T-cell depletion and novel approaches to reduce and treat graft-versus-host disease. Dr. Kamble is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Multiple Myeloma, Graft Versus Host Disease (GvHD), Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Graft.
Hector Carbajal is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Carbajal is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Liver Failure, Ascites, Jaundice, Liver Embolization, and Bone Marrow Aspiration. Dr. Carbajal is currently accepting new patients.
Terry Rice is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Rice is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Febrile Neutropenia, Multiple Myeloma, Pulmonary Embolism, and Agranulocytosis.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerDr. Vu isExperienced. Learn about Breast Cancer.
- Childhood Acute Myeloid Leukemia
- Deep Vein ThrombosisDr. Vu isExperienced. Learn about Deep Vein Thrombosis.
- Familial HypertensionDr. Vu isExperienced. Learn about Familial Hypertension.
- Fibrolamellar CarcinomaDr. Vu isExperienced. Learn about Fibrolamellar Carcinoma.
- FibrosarcomaDr. Vu isExperienced. Learn about Fibrosarcoma.